| ASSET | % RETURN |
|---|---|
AXT (AXTI) | 3,890.78% |
Kodiak Sciences (KOD) | 1,936.36% |
Tango Therapeutics (TNGX) | 1,568.8% |
Abivax SA American Depositary Shares (ABVX) | 1,096.4% |
Erasca (ERAS) | 933.79% |
10X Genomics (TXG) | 779.04% |
Oruka Therapeutics (ORKA) | 740.28% |
Ondas (ONDS) | 689.74% |
Praxis Precision Medicines (PRAX) | 614.18% |
ViaSat (VSAT) | 611.58% |
Sellas Life Sciences (SLS) | 606.98% |
MaxLinear (MXL) | 545.34% |
Delek US Energy (DK) | 529.08% |
Spyre Therapeutics (SYRE) | 511.25% |
Cogent Biosciences (COGT) | 492.15% |
Celcuity LLC (CELC) | 490.13% |
Par Pacific (PARR) | 477.57% |
Definium Therapeutics (DFTX) | 458.37% |
Relay Therapeutics (RLAY) | 445.78% |
Applied Opt (AAOI) | 437.27% |
Amylyx Pharmaceuticals (AMLX) | 430.14% |
Figs (FIGS) | 414.32% |
PACS (PACS) | 408.45% |
Okeanis Eco Tankers (ECO) | 402.22% |
Calumet Specialty Products Partners (CLMT) | 392.17% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.